Hsiao-Mei Chao

Hsiao-Mei Chao

Auto-generated profile, based on publicly available information

Hsiao-Mei Chao

NiChe Lab for Stem Cell and Regenerative Medicine, Department of Biochemical Science and Technology, National Taiwan University, Taipei 10617, Taiwan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PCPo-Hsiang Chang
Po-Hsiang Chang
KSKeisuke Sekine
Keisuke Sekine
HCHsiao-Mei Chao
Hsiao-Mei Chao
Shan-hui HsuShan-hui Hsu
Shan-hui Hsu
ECEdward Chern
Edward Chern
Cancer stem cells (CSCs), a small population of cancer cells, have been considered to be the origin of cancer initiation, recurrence, and metastasis. Tumor microenvironment provides crucial signals for CSCs to maintain stem cell properties and promotes tumorigenesis. Therefore, establishment of an appropriate cell culture system to mimic the microenvironment for CSC studies is an important issue. In this study, we grew colon and hepatocellular carcinoma (HCC) cells on chitosan membranes and evaluated the tumor progression and the CSC properties. Experimental results showed that culturing cancer cells on chitosan increased cell motility, drug resistance, quiescent population, self-renewal capacity, and the expression levels of stemness and CSC marker genes, such as OCT4, NANOG, CD133, CD44, and EpCAM. Furthermore, we demonstrated that chitosan might activate canonical Wnt/β-catenin-CD44 axis signaling in CD44positive colon cancer cells and noncanonical Wnt-STAT3 signaling in CD44negative HCC cells. In conclusion, chitosan as culture substrates activated the essential signaling of CSCs and promoted CSC properties. The chitosan culture system provides a convenient platform for the research of CSC biology and screening of anticancer drugs.

1 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
HCHsiao-Mei Chao
Hsiao-Mei Chao
HHHong-Xuan Huang
Hong-Xuan Huang
PCPo-Hsiang Chang
Po-Hsiang Chang
KTKuo-Chang Tseng
Kuo-Chang Tseng
AMAtsushi Miyajima
Atsushi Miyajima
ECEdward Chern
Edward Chern
Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway

1 December 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
TWTeh-Wei Wang
Teh-Wei Wang
ECEdward Chern
Edward Chern
CHChao-Wei Hsu
Chao-Wei Hsu
KTKuo-Chang Tseng
Kuo-Chang Tseng
HCHsiao-Mei Chao
Hsiao-Mei Chao
NAD-dependent deacetylase sirtuin-1 (SIRT1) is a class III histone deacetylase that positively regulates cancer-related pathways such as proliferation and stress resistance. SIRT1 has been shown to promote progression of colorectal cancer and is associated with cancer stemness, yet the precise mechanism between colorectal cancer stemness and SIRT1 remains to be further clarified. Here we report that SIRT1 signaling regulates colorectal cancer stemness by enhancing expression of CD24, a colorectal cancer stemness promoter. A novel miRNA, miR-1185-1, suppressed the expression of CD24 by targeting its 3′UTR (untranslated region) and could be inhibited by SIRT1 via histone deacetylation. Targeting SIRT1 by RNAi led to elevated H3 lysine 9 acetylation on the promoter region of miR-1185-1, which increased expression of miR-1185-1 and further repressed CD24 translation and colorectal cancer stemness. In a mouse xenograft model, overexpression of miR-1185-1 in colorectal cancer cells substantially reduced tumor growth. In addition, expression of miR-1185-1 was downregulated in human colorectal cancer tissues, whereas expression of CD24 was increased. In conclusion, this study not only demonstrates the essential roles of a SIRT1–miR-1185-1–CD24 axis in both colorectal cancer stemness properties and tumorigenesis but provides a potential therapeutic target for colorectal cancer treatment. Significance: A novel tumor suppressor miR-1185-1 is involved in molecular regulation of CD24- and SIRT1-related cancer stemness networks, marking it a potential therapeutic target in colorectal cancer.

15 February 2018 in Materials
Verified
Journal Article
Open access
PDF file
MCMing-Ju Chou
Ming-Ju Chou
HYHsing-Yi Yu
Hsing-Yi Yu
JHJui-Ching Hsia
Jui-Ching Hsia
YCYing-Hou Chen
Ying-Hou Chen
THTzu-Ting Hung
Tzu-Ting Hung
PHPhD. Huang
PhD. Huang
Intracellular protein delivery may provide a safe and non-genome integrated strategy for targeting abnormal or specific cells for applications in cell reprogramming therapy. Thus, highly efficient intracellular functional protein delivery would be beneficial for protein drug discovery. In this study, we generated a cationic polyethyleneimine (PEI)-modified gelatin nanoparticle and evaluated its intracellular protein delivery ability in vitro and in vivo. The experimental results showed that the PEI-modified gelatin nanoparticle had a zeta potential of approximately +60 mV and the particle size was approximately 135 nm. The particle was stable at different biological pH values and temperatures and high protein loading efficiency was observed. The fluorescent image results revealed that large numbers of particles were taken up into the mammalian cells and escaped from the endosomes into the cytoplasm. In a mouse C26 cell-xenograft cancer model, particles accumulated in cancer cells. In conclusion, the PEI-modified gelatin particle may provide a biodegradable and highly efficient protein delivery system for use in regenerative medicine and cancer therapy.

6 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
WCWei Cheng
Wei Cheng
PHPo-Chun Huang
Po-Chun Huang
HCHsiao-Mei Chao
Hsiao-Mei Chao
YJYung-Ming Jeng
Yung-Ming Jeng
HHHey-Chi Hsu
Hey-Chi Hsu
YLYu-May Lee
Yu-May Lee
Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10 Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10

1 February 2022 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
KLKai-Yuan Liu
Kai-Yuan Liu
HCHsiao-Mei Chao
Hsiao-Mei Chao
YLYen-Jung Lu
Yen-Jung Lu
YSYing-Shih Su
Ying-Shih Su
WLWen-Sen Lee
Wen-Sen Lee
Cytomegalovirus (CMV) infection is associated with significant morbidity and mortality in both immunocompetent and immunocompromised patients. CMV is a ubiquitous Herpesviridae virus with a wide spectrum of pathologies in humans. Immunocompetent patients generally develop a benign, self-limited mononucleosis-like syndrome, whereas gastrointestinal tissue-invasive disease is more frequently seen in immunocompromised. The clinical manifestations of CMV colitis or proctitis are demarcated by bloody diarrhea, ulcerations, ulcero-infiltrative changes, and pseudomembranous formation on colonoscopy. Gastrointestinal CMV infections complicated with deep rectal ulcer and fistula formation are rare in patients with systemic lupus erythematosus. Ganciclovir is also the gold standard therapy for CMV colitis or proctitis.